Company Overview and News

 
Govt to sell its stake in SJVN Power Finance Corp for Rs 20,000 crore: Report

6h moneycontrol
The Centre plans to sell stake in hydropower producer SJVN and Power Finance Corporation to other public sector companies to net close to Rs 20,000 crore to help maintain its FY19 fiscal deficit target, sources told Bloomberg.
PFC PWQFY 532955 RECLTD 532810

 
Govt mulls selling stake in PFC to REC

14h freepressjournal.in
New Delhi : The government is considering selling its 65.61 per cent stake in state-owned Power Finance Corporation (PFC) to Rural Electrification Corporation (REC), which could fetch the exchequer about Rs 13,000 crore.
PFC PWQFY 532955 RECLTD 532810

 
India plans power sector mergers to raise ₹ 20,000 crore

2018-09-24 livemint
New Delhi: India is planning to sell its stake in SJVN Ltd and Power Finance Corp. to other government-controlled companies in deals that may fetch the federal government about ₹ 20,000 crore, helping it to rein in the fiscal deficit amid growing risks of a slippage, people with knowledge of the matter said.
PFC PWQFY HINDPETRO 500104 532955 RECLTD 532810 NTPZY

 
Government mulls selling its stake in PFC to REC

2018-09-24 moneycontrol
The government is considering selling its 65.61 percent stake in state-owned Power Finance Corporation (PFC) to Rural Electrification Corporation (REC), which could fetch the exchequer about Rs 13,000 crore. "The discussions are at a preliminary stage. The government sees a lot of synergy between the two NBFCs funding power sector projects," an official said.
PFC PWQFY 532955 RECLTD 532810

 
Small lenders to submit report on stressed power assets by October 10

2018-09-21 moneycontrol
Small lenders will submit their resolution plans on stressed power assets to a group of bankers and assess the situation on October 10, Financial Express reported quoting people aware of the development.
PWQFY 500116 AXB IBN IDBI 532810 532215 AXBKY PFC AXBA ICICIBANK PNJZY 532461 AXISBANK 532174 PNB SBAZ

 
India banks to plan resolving $19 billion power sector debt on Thursday

2018-09-19 livemint
Mumbai/New Delhi: Lenders to India’s power industry are scheduled to meet on Thursday to discuss ways to resolve ₹1.4 trillion ($19.2 billion) of stressed assets that’s hobbling the sector, people with knowledge of the matter said.
PFC PWQFY 532627 JPPOWER 532955 RECLTD 532810 SBAZ

 
Power Finance Corp moves NCLT, files insolvency plea against Rattan India

2018-09-18 economictimes.indiatimes
Copyright © 2018 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service
PFC PWQFY 532810

 
Power Finance Corp moves NCLT against Rattan India

2018-09-18 moneycontrol
State-owned Power Finance Corp (PFC) has filed an insolvency plea against Rattan India Power, formerly known as Indiabulls Power, in the National Company Law Tribunal (NCLT) to recover unpaid loans.
PFC PWQFY 532810

 
PFC to close resolution plans of 5 stressed assets in 1 month: CMD

2018-09-12 moneycontrol
Power Finance Corporation said Wednesday the worst was behind for stressed power assets and it would finalise resolution plans with five struggling projects with an exposure of Rs 8,254 crore in one month. The state-run company said it had been working with other lenders of these projects for resolution.
PFC PWQFY 532810

 
Power Finance Corporation declines 6% post Q1 numbers

2018-09-11 moneycontrol
Shares of Power Finance Corporation (PFC) declined 6.6 percent intraday Tuesday despite company posted strong numbers for the quarter ended June 2018.
PFC PWQFY 532810

 
PFC, Reliance Capital, Pratibha Ind results

2018-09-10 thehindubusinessline
Power Finance Corporation and Reliance Capital will declare their unaudited financial results for the quarter ended June 2018 on Tuesday. The board of Pratibha Industries will consider the audited, standalone, and consolidated financial results for the quarter and financial year ended March 31, 2018. Focus will be on Reliance Capital’s results. It had reported a profit of ₹212 crore for the quarter ended March 2018 and ₹190 crore in the June 2017 quarter.
PFC PWQFY RELCAPITAL 532718 PRATIBHA 532810 500111

 
Power Finance Corporation (₹87): Buy

2018-09-06 premium.thehindubusinessline
Investors with a short-term perspective can buy the stock of Power Finance Corporation (PFC) at current levels. The stock picked up bullish momentum on Thursday and surged 4 per cent with an above average volume breaching a key resistance at ₹84. Moreover, the stock has decisively breached its 21-day moving average and hovers well above its 50-day moving average as well.
PFC PWQFY 532810

 
As power sector resolution reaches endgame, lenders in investor focus

2018-08-31 livemint
The Allahabad high court’s decision to deny relief to power companies facing debt servicing problems may have stoked fears of a fresh bout of write-offs for the banking sector. But the decision has triggered a rally in the shares of Power Finance Corp. Ltd (PFC), Rural Electrification Corp. Ltd (REC) and PTC India Financial Services Ltd. The stocks gained 6-8% over the last four days.
PFC PFS PWQFY 532955 RECLTD 532810 533344

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

6m - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

Silicon Investor Message Boards

This table lists all message boards related to NSE:PFC / POWER FINANCE CORPORATION LTD. on message board site Silicon Investor.

American Pacific (APFC)-Specialty Chemicals American Pacific (APFC)-Specialty Chemicals American Pacific (APFC)-Specialty Chemicals PFCE PFCE PFCE
PFCB: P.F. Changu0027s China Bistro PFCB: P.F. Changu0027s China Bistro PFCB: P.F. Changu0027s China Bistro PFCK Gets $50 million cash infusion PFCK Gets $50 million cash infusion PFCK Gets $50 million cash infusion
PFCK: Peacock Financial Corp. PFCK: Peacock Financial Corp. PFCK: Peacock Financial Corp. Lotus Pacific Inc. (LPFC) Lotus Pacific Inc. (LPFC) Lotus Pacific Inc. (LPFC)
New CMGI in Development look at PFCK New CMGI in Development look at PFCK New CMGI in Development look at PFCK PFCS PFCS PFCS
PF Changu0027s China Bistro (PFCB) PF Changu0027s China Bistro (PFCB) PF Changu0027s China Bistro (PFCB) Pacific Galleon Resources Pacific Galleon Resources Pacific Galleon Resources